This information is current as Signaling in CD 8 T Cells S 6 Phosphorylation to Control Metabolic Converge at the Level of Ribosomal Protein Mammalian Target of Rapamycin Pathways MAPK , Phosphatidylinositol 3-Kinase , and

Ribosomal protein S6 (rpS6) is a key component of the translational machinery in eukaryotic cells and is essential for ribosome biogenesis. rpS6 is phosphorylated on evolutionarily conserved serine residues, and data indicate that rpS6 phosphorylation might regulate cell growth and protein synthesis. Studies in cell lines have shown an important role for the serine kinase mammalian target of rapamycin (mTOR) in rpS6 phosphorylation, further linking rpS6 to control of cellular metabolism. rpS6 is essential in T cells because its deletion in mouse double-positive thymocyte cells results in a complete block in T cell development; however, the signaling pathway leading to rpS6 phosphorylation downstream of TCR stimulation has yet to be fully characterized. We show that maximal TCR-induced rpS6 phosphorylation in CD8 T cells requires both Lck and Fyn activity and downstream activation of PI3K, mTOR, and MEK/ERK MAPK pathways. We demonstrate that there is cross-talk between the PI3K and MAPK pathways as well as PI3K-independent mTOR activity, which result in differential phosphorylation of specific rpS6 serine residues. These results place rpS6 phosphorylation as a point of convergence for multiple crucial signaling pathways downstream of TCR triggering.

[1]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[2]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[3]  D. Cantrell,et al.  New insights into the regulation and function of serine/threonine kinases in T lymphocytes , 2009, Immunological reviews.

[4]  Stefano Caserta,et al.  T‐cell receptor proximal signaling via the Src‐family kinases, Lck and Fyn, influences T‐cell activation, differentiation, and tolerance , 2009, Immunological reviews.

[5]  R. Mills,et al.  T cell dependence on mTOR signaling , 2009, Cell cycle.

[6]  David M. Sabatini,et al.  The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.

[7]  David K. Finlay,et al.  Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking , 2008, Nature Immunology.

[8]  J. Backer.  The regulation and function of Class III PI3Ks: novel roles for Vps34. , 2008, The Biochemical journal.

[9]  K. Okkenhaug,et al.  CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. , 2008, Blood.

[10]  Jian-xin Lin,et al.  Critical role for Rsk2 in T-lymphocyte activation. , 2008, Blood.

[11]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[12]  D. F. Barber,et al.  Phosphoinositide 3–kinase γ participates in T cell receptor–induced T cell activation , 2007, The Journal of experimental medicine.

[13]  Amber C. Donahue,et al.  Distinct signaling mechanisms activate the target of rapamycin in response to different B‐cell stimuli , 2007, European journal of immunology.

[14]  B. Schraven,et al.  Fyn Regulates the Duration of TCR Engagement Needed for Commitment to Effector Function1 , 2007, The Journal of Immunology.

[15]  J. Blenis,et al.  RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation* , 2007, Journal of Biological Chemistry.

[16]  J. Powell,et al.  A Role for Mammalian Target of Rapamycin in Regulating T Cell Activation versus Anergy1 , 2007, The Journal of Immunology.

[17]  D. Brautigan,et al.  Phosphorylation and functions of inhibitor-2 family of proteins. , 2007, Biochemistry.

[18]  K. Okkenhaug,et al.  Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3K , 2007, Trends in immunology.

[19]  B. Schraven,et al.  PAG-Associated FynT Regulates Calcium Signaling and Promotes Anergy in T Lymphocytes , 2007, Molecular and Cellular Biology.

[20]  K. Okkenhaug,et al.  The p110δ Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells1 , 2006, The Journal of Immunology.

[21]  E. Palmer,et al.  Lck Regulates the Threshold of Activation in Primary T Cells, While both Lck and Fyn Contribute to the Magnitude of the Extracellular Signal-Related Kinase Response , 2006, Molecular and Cellular Biology.

[22]  K. Okkenhaug,et al.  Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. , 2006, Blood.

[23]  Sanda Šulić,et al.  Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. , 2005, Genes & development.

[24]  Craig B. Thompson,et al.  Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.

[25]  J. Pouysségur,et al.  The role of erk1 and erk2 in multiple stages of T cell development. , 2005, Immunity.

[26]  Yuval Dor,et al.  Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. , 2005, Genes & development.

[27]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[28]  Stefano Fumagalli,et al.  S6K1−/−/S6K2−/− Mice Exhibit Perinatal Lethality and Rapamycin-Sensitive 5′-Terminal Oligopyrimidine mRNA Translation and Reveal a Mitogen-Activated Protein Kinase-Dependent S6 Kinase Pathway , 2004, Molecular and Cellular Biology.

[29]  N. Oshiro,et al.  Raptor, a binding partner of target of rapamycin. , 2004, Biochemical and biophysical research communications.

[30]  D. Hafler,et al.  Rapamycin-resistant Proliferation of CD8+ T Cells Correlates with p27kip1 Down-regulation and bcl-xL Induction, and Is Prevented by an Inhibitor of Phosphoinositide 3-Kinase Activity* , 2004, Journal of Biological Chemistry.

[31]  J. Lehman,et al.  Mechanism of Ribosomal p70S6 Kinase Activation by Granulocyte Macrophage Colony-stimulating Factor in Neutrophils , 2003, Journal of Biological Chemistry.

[32]  J. Blenis,et al.  Characterization of Phosphatidylinositol 3-Kinase-dependent Phosphorylation of the Hydrophobic Motif Site Thr389 in p70 S6 Kinase 1* , 2002, The Journal of Biological Chemistry.

[33]  N. Zavazava,et al.  P59fyn is upregulated in anergic CD8+ T cells , 2002 .

[34]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[35]  J. Avruch,et al.  Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.

[36]  K. Okkenhaug,et al.  Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.

[37]  C. Thompson,et al.  Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. , 2002, Molecular biology of the cell.

[38]  S. Hanash,et al.  Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and Proteomics* , 2002, The Journal of Biological Chemistry.

[39]  D. Hafler,et al.  Uncoupling p70s6 Kinase Activation and Proliferation: Rapamycin-Resistant Proliferation of Human CD8+ T Lymphocytes1 , 2001, The Journal of Immunology.

[40]  O. Meyuhas.  Synthesis of the translational apparatus is regulated at the translational level. , 2000, European journal of biochemistry.

[41]  D. Kioussis,et al.  Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes. , 2000, Immunity.

[42]  Jürgen R. Müller,et al.  Conversion of p56lck to p60lck in human peripheral blood T lymphocytes is dependent on co‐ stimulation through accessory receptors: involvement of phospholipase C, protein kinase C and MAP‐kinases in vivo , 2000, European journal of immunology.

[43]  G. Thomas,et al.  The modular phosphorylation and activation of p70s6k , 1997, FEBS letters.

[44]  R. Abraham,et al.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002. , 1996, The EMBO journal.

[45]  A. Gingras,et al.  Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation. , 1996, The EMBO journal.

[46]  G. Crabtree,et al.  Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase , 1992, Nature.

[47]  G. Crabtree,et al.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.

[48]  N. Sigal,et al.  Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. , 1990, Journal of immunology.

[49]  P. Cohen,et al.  BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. , 2007, The Biochemical journal.

[50]  Amber C. Donahue,et al.  Measuring phosphorylated Akt and other phosphoinositide 3-kinase-regulated phosphoproteins in primary lymphocytes. , 2007, Methods in enzymology.